Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Personality traits and escitalopram treatment outcome in major depression.

Aluoja A, Tõru I, Raag M, Eller T, Võhma Ü, Maron E.

Nord J Psychiatry. 2018 Jul;72(5):354-360. doi: 10.1080/08039488.2018.1465590. Epub 2018 Apr 24.

PMID:
29688152
2.

Whole-genome expression analysis reveals genes associated with treatment response to escitalopram in major depression.

Pettai K, Milani L, Tammiste A, Võsa U, Kolde R, Eller T, Nutt D, Metspalu A, Maron E.

Eur Neuropsychopharmacol. 2016 Sep;26(9):1475-1483. doi: 10.1016/j.euroneuro.2016.06.007. Epub 2016 Jul 22.

PMID:
27461515
3.

Polymorphisms of IKBKE gene are associated with major depressive disorder and panic disorder.

Traks T, Koido K, Balõtšev R, Eller T, Kõks S, Maron E, Tõru I, Shlik J, Vasar E, Vasar V.

Brain Behav. 2015 Apr;5(4):e00314. doi: 10.1002/brb3.314. Epub 2015 Feb 13.

4.

Whole-exome sequencing identifies a polymorphism in the BMP5 gene associated with SSRI treatment response in major depression.

Tammiste A, Jiang T, Fischer K, Mägi R, Krjutškov K, Pettai K, Esko T, Li Y, Tansey KE, Carroll LS, Uher R, McGuffin P, Võsa U, Tšernikova N, Saria A, Ng PC, Eller T, Vasar V, Nutt DJ, Maron E, Wang J, Metspalu A.

J Psychopharmacol. 2013 Oct;27(10):915-20. doi: 10.1177/0269881113499829. Epub 2013 Aug 7.

PMID:
23926243
5.

Soluble interleukin-2 receptor and tumor necrosis factor levels in depressed patients in Estonia.

Eller T, Aluoja A, Maron E, Vasar V.

Medicina (Kaunas). 2009;45(12):971-7.

6.

Obstructive sleep apnea syndrome (OSAS): Pathophysiology in Estonians.

Veldi M, Ani R, Vaher H, Eller T, Hion T, Aluoja A, Vasar V.

Pathophysiology. 2010 Jun;17(3):219-23. doi: 10.1016/j.pathophys.2010.01.001. Epub 2010 Feb 8.

PMID:
20116218
7.

Thyroid autoimmunity and treatment response to escitalopram in major depression.

Eller T, Metsküla K, Talja I, Maron E, Uibo R, Vasar V.

Nord J Psychiatry. 2010 Aug;64(4):253-7. doi: 10.3109/08039480903487533.

PMID:
20088751
8.

Interleukin 10 family gene polymorphisms are not associated with major depressive disorder and panic disorder phenotypes.

Koido K, Eller T, Kingo K, Kõks S, Traks T, Shlik J, Vasar V, Vasar E, Maron E.

J Psychiatr Res. 2010 Apr;44(5):275-7. doi: 10.1016/j.jpsychires.2009.09.001. Epub 2009 Sep 27.

PMID:
19786281
9.

Effects of bupropion augmentation in escitalopram-resistant patients with major depressive disorder: an open-label, naturalistic study.

Maron E, Eller T, Vasar V, Nutt DJ.

J Clin Psychiatry. 2009 Jul;70(7):1054-6. No abstract available.

PMID:
19653982
10.

The role of IL-2 and soluble IL-2R in depression and antidepressant response.

Eller T, Vasar V, Shlik J, Maron E.

Curr Opin Investig Drugs. 2009 Jul;10(7):638-43. Review.

PMID:
19579169
11.

Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression.

Maron E, Tammiste A, Kallassalu K, Eller T, Vasar V, Nutt DJ, Metspalu A.

Eur Neuropsychopharmacol. 2009 Jun;19(6):451-6. doi: 10.1016/j.euroneuro.2009.01.010. Epub 2009 Mar 9.

PMID:
19272758
12.

Polymorphisms in the interleukin-10 gene cluster are possibly involved in the increased risk for major depressive disorder.

Traks T, Koido K, Eller T, Maron E, Kingo K, Vasar V, Vasar E, Kõks S.

BMC Med Genet. 2008 Dec 16;9:111. doi: 10.1186/1471-2350-9-111.

13.

Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder.

Eller T, Vasar V, Shlik J, Maron E.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Feb 15;32(2):445-50. Epub 2007 Sep 26.

PMID:
17976882
14.

Symptoms of anxiety and depression in Estonian medical students with sleep problems.

Eller T, Aluoja A, Vasar V, Veldi M.

Depress Anxiety. 2006;23(4):250-6.

PMID:
16555263

Supplemental Content

Loading ...
Support Center